Pulmonary Medicine最新文献

{"title":"Chronic Obstructive Pulmonary Disease in Cameroon: Prevalence and Predictors-A Multisetting Community-Based Study.","authors":"Massongo Massongo,&nbsp;Adamou Dodo Balkissou,&nbsp;Laurent-Mireille Endale Mangamba,&nbsp;Virginie Poka Mayap,&nbsp;Marie Elisabeth Ngah Komo,&nbsp;Abdou Wouoliyou Nsounfon,&nbsp;Alain Kuaban,&nbsp;Eric Walter Pefura Yone","doi":"10.1155/2023/1631802","DOIUrl":"https://doi.org/10.1155/2023/1631802","url":null,"abstract":"<p><strong>Objective: </strong>Little is known concerning chronic obstructive pulmonary disease (COPD) in Sub-Saharan Africa (SSA), where the disease remains underdiagnosed. We aimed to estimate its prevalence in Cameroon and look for its predictors.</p><p><strong>Methods: </strong>Adults aged 19 years and older were randomly selected in 4 regions of Cameroon to participate in a cross-sectional community-based study. Data were collected in the participant's home or place of work. Spirometry was performed on selected participants. COPD was defined as the postbronchodilator forced expiratory volume in 1 second/forced vital capacity ratio (FEV1/FVC) < lower limit of normal, using the global lung initiative (GLI) equations for Black people. Binomial logistic regression was used to seek COPD-associated factors. The strength of the association was measured using the adjusted odds ratio (aOR).</p><p><strong>Results: </strong>A total of 5055 participants (median age (25^th-75^th percentile) = 43 (30-56) years, 54.9% of women) were enrolled. COPD prevalence (95% confidence interval (95% CI)) was 2.9% (2.4, 3.3)%. Independent predictors of COPD (aOR (95% CI)) were a high educational level (4.7 (2.0, 11.1)), living in semiurban or rural locality (1.7 (1.4, 3.0)), tobacco smoking (1.7 (1.1, 2.5)), biomass fuel exposure (1.9 (1.1, 3.3)), experience of dyspnea (2.2 (1.4, 3.5)), history of tuberculosis (3.6 (1.9, 6.7)), and history of asthma (6.3 (3.4, 11.6)). Obesity was protective factor (aOR (95%CI) = 0.3 (0.2, 0.5)).</p><p><strong>Conclusion: </strong>The prevalence of COPD was relatively low. Alternative risk factors such as biomass fuel exposure, history of tuberculosis, and asthma were confirmed as predictors.</p>","PeriodicalId":46434,"journal":{"name":"Pulmonary Medicine","volume":"2023 ","pages":"1631802"},"PeriodicalIF":4.3,"publicationDate":"2023-09-13","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10511289/pdf/","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"41165915","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}

{"title":"Patient Perspectives on the Use of Digital Technology to Help Manage Cystic Fibrosis.","authors":"Alexandre H Watanabe, Connor Willis, Russell Ragsdale, Joseph Biskupiak, Karlene Moore, Diana Brixner, David Young","doi":"10.1155/2023/5082499","DOIUrl":"10.1155/2023/5082499","url":null,"abstract":"<p><strong>Background: </strong>Digital health technologies (DHTs) have shown potential to improve health outcomes through improved medication adherence in different disease states. Cystic fibrosis (CF) requires care coordination across pharmacies, patients, and providers. DHTs can potentially support patients, providers, and pharmacists in diseases like CF, where high medication burden can negatively impact patient quality of life and outcomes.</p><p><strong>Methods: </strong>In this prospective cohort study, a CF-specific mobile application (Phlo) was distributed to adults with CF who received care at the University of Utah Cystic Fibrosis Center, used an iPhone, and filled prescriptions through the University of Utah Specialty Pharmacy services. Participants were asked to use Phlo for 90 days with an optional 90-day extension period. Participants completed four surveys at baseline and after 90 days. Changes in patient-reported outcomes, adherence, clinical outcomes, and healthcare resource utilization from baseline to 90 days were tracked.</p><p><strong>Results: </strong>Phlo allowed users to track daily regimen activities, contact their care team, receive medication delivery reminders, and share progress with their healthcare team. A web-based dashboard allowed the care team to review reported performance scores from the app. Most patients (67%) said the app improved confidence in and motivation for continuing their regimen. The most important reported benefit of Phlo was having a single location to manage their whole routine.</p><p><strong>Conclusions: </strong>Phlo is a mobile health technology designed to help patients with CF manage their treatment regimen and improve patient-provider communication.</p>","PeriodicalId":46434,"journal":{"name":"Pulmonary Medicine","volume":"2023 ","pages":"5082499"},"PeriodicalIF":2.0,"publicationDate":"2023-01-23","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9886457/pdf/","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"10640031","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}

{"title":"Home Respiratory Polygraphy and Spirometry in Normal Weight and Children with Obesity Suspected for Obstructive Sleep Apnea Syndrome: Are There Any Associations?","authors":"Regula Corbelli,&nbsp;Constance Barazzone,&nbsp;Carole Grasset Salomon,&nbsp;Maurice Beghetti,&nbsp;Albane B R Maggio","doi":"10.1155/2023/1532443","DOIUrl":"https://doi.org/10.1155/2023/1532443","url":null,"abstract":"<p><strong>Aim: </strong>It is known that children and adolescents with obesity are more prone to obstructive sleep apnea syndrome (OSAS) and that their lung function may show some disturbance. Literature is scarce about potential associations; therefore, we aimed to study the relationship between OSAS, lung function, and adiposity in a population of children suspected of OSAS. <i>Material and Methods</i>. We performed home respiratory polygraphy and spirometry in all subjects. The relationships between body mass index <i>z</i>-score (zBMI), polygraphy, and spirometry data were analyzed.</p><p><strong>Results: </strong>We recruited 81 subjects aged between 5 and 16 years, 63% being obese. 43.2% of subjects were diagnosed with OSAS (32.1% mild, 4.9% moderate, and 6.2% severe). We found no correlation between respiratory polygraphy and the zBMI. The mean spirometric value FEV₁, FVC, and FEV₁/FVC ratio <i>z</i>'s were normal in all subjects, whereas FVC <i>z</i>'s and FEV₁/FVC ratio <i>z</i>'s were significantly positively related for obesity and negatively for normal weight (<i>p</i> < 0.05). FEV₁ <i>z</i>'s was inversely correlated to the percentage of analyzed time passed below 90% of SpO₂ (<i>r</i> = -0.224, <i>p</i> = 0.044). All subjects with FEV₁ (<i>n</i> = 8) and/or FVC (<i>n</i> = 9) <i>z</i>'s below the lower limit for normal (LLN) had an AHI ≥ 1 (FEV₁: <i>p</i> = 0.001; FVC: <i>p</i> < 0.001), especially subjects with normal weight (FEV₁: <i>p</i> = 0.003; FVC: <i>p</i> = 0.010).</p><p><strong>Conclusion: </strong>When comparing normal-weight children and adolescents with obesity, the prevalence of OSAS but not spirometric values was strongly related to BMI <i>z</i>-score, probably because obesity engenders advanced puberty and an accelerated growth spurt. FEV₁ was more frequently <LLN in normal-weight children, while obese subjects presented low FEV₁/FVC ratio <i>z</i>'s and FEF_25-75% <i>z</i>'s. Moreover, all subjects with abnormal spirometric values were suffering from at least mild OSAS, again more frequently in normal-weight subjects.</p>","PeriodicalId":46434,"journal":{"name":"Pulmonary Medicine","volume":"2023 ","pages":"1532443"},"PeriodicalIF":4.3,"publicationDate":"2023-01-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9906030/pdf/","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"10692322","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}

{"title":"Pediatric COVID-19: Correlations between Clinical and Imaging Perspectives.","authors":"Heba A Ali,&nbsp;Shaimaa A Mohammad","doi":"10.1155/2023/4159651","DOIUrl":"https://doi.org/10.1155/2023/4159651","url":null,"abstract":"<p><strong>Background: </strong>Although SARS-CoV-2 infection primarily affects adults, the increasing emergence of infected pediatric patients has been recently reported. However, there is a paucity of data regarding the value of imaging in relation to the clinical severity of this pandemic emergency.</p><p><strong>Objectives: </strong>To demonstrate the relationships between clinical and radiological COVID-19 findings and to determine the most effective standardized pediatric clinical and imaging strategies predicting the disease severity. <i>Patients and Methods</i>. This observational study enrolled eighty pediatric patients with confirmed COVID-19 infection. The studied patients were categorized according to the disease severity and the presence of comorbidities. Patients' clinical findings, chest X-ray, and CT imaging results were analyzed. Patients' evaluations using several clinical and radiological severity scores were recorded. The relations between clinical and radiological severities were examined.</p><p><strong>Results: </strong>Significant associations were found between severe-to-critical illness and abnormal radiological findings (<i>p</i> = 0.009). In addition, chest X-ray score, chest CT severity score, and rapid evaluation of anamnesis, PO2, imaging disease, and dyspnea-COVID (RAPID-COVID) score were significantly higher among patients with severe infection (<i>p</i> < 0.001, <0.001, and 0.001) and those with comorbidities (<i>p</i> = 0.005, 0.002, and <0.001).</p><p><strong>Conclusions: </strong>Chest imaging of pediatric patients with COVID-19 infection may be of value during the evaluation of severe cases of infected pediatric patients and in those with underlying comorbid conditions, especially during the early stage of infection. Moreover, the combined use of specific clinical and radiological COVID-19 scores are likely to be a successful measure of the extent of disease severity.</p>","PeriodicalId":46434,"journal":{"name":"Pulmonary Medicine","volume":"2023 ","pages":"4159651"},"PeriodicalIF":4.3,"publicationDate":"2023-01-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10171977/pdf/","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"9469322","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}

{"title":"Characteristics, Management, and Outcomes of Community-Acquired Pneumonia due to Respiratory Syncytial Virus: A Retrospective Study.","authors":"Ibrahim Bahabri,&nbsp;Abdulaziz Abdulaal,&nbsp;Thamer Alanazi,&nbsp;Sultan Alenazy,&nbsp;Yasser Alrumih,&nbsp;Rakan Alqahtani,&nbsp;Sameera Al Johani,&nbsp;Mohammad Bosaeed,&nbsp;Hasan M Al-Dorzi","doi":"10.1155/2023/4310418","DOIUrl":"https://doi.org/10.1155/2023/4310418","url":null,"abstract":"<p><strong>Background: </strong>Respiratory syncytial virus (RSV), a well-known cause of bronchiolitis in children, can cause community-acquired pneumonia (CAP) in adults, but this condition is not well studied. Hence, we described the characteristics and outcomes of patients hospitalized for CAP due to RSV.</p><p><strong>Methods: </strong>This was a retrospective study of patients admitted to a tertiary-care hospital between 2016 and 2019 with CAP due to RSV diagnosed by a respiratory multiplex PCR within 48 hours of admission. We compared patients who required ICU admission to those who did not.</p><p><strong>Results: </strong>Eighty adult patients were hospitalized with CAP due to RSV (median age 69.0 years, hypertension 65.0%, diabetes 58.8%, chronic respiratory disease 52.5%, and immunosuppression 17.5%); 19 (23.8%) patients required ICU admission. The median pneumonia severity index score was 120.5 (140.0 for ICU and 102.0 for non-ICU patients; <i>p</i> = 0.09). Bacterial coinfection was rare (10.0%). Patients who required ICU admission had more hypotension (systolic blood pressure < 90 mmHg) and a higher prevalence of bilateral infiltrates on chest X-ray (CXR) (89.5% versus 32.7%; <i>p</i> < 0.001). Systemic corticosteroids were used in 57.3% of patients (median initial dose was 40 mg of prednisone equivalent) with ICU patients receiving a higher dose compared to non-ICU patients (<i>p</i> = 0.02). Most (68.4%) ICU patients received mechanical ventilation (median duration of 4 days). The overall hospital mortality was 8.8% (higher for ICU patients: 31.6% versus 1.6%, <i>p</i> < 0.001).</p><p><strong>Conclusions: </strong>Most patients with CAP due to RSV were elderly and had significant comorbidities. ICU admission was required in almost one in four patients and was associated with higher mortality.</p>","PeriodicalId":46434,"journal":{"name":"Pulmonary Medicine","volume":"2023 ","pages":"4310418"},"PeriodicalIF":4.3,"publicationDate":"2023-01-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10010887/pdf/","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"9507291","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}

{"title":"Respiratory Disorders Related to e-Waste Exposure among Workers in the Informal Sector in a Sub-Saharan African City: An Exposed Nonexposed Study","authors":"A. Wachinou, N. Kedote, Géraud Padonou, S. Ade, J. Darboux, Mirlène Tohi, A. Fiogbe, J. Fobil, G. Agodokpessi","doi":"10.1155/2022/9968897","DOIUrl":"https://doi.org/10.1155/2022/9968897","url":null,"abstract":"Introduction Exposure to electrical and electronic equipment waste (e-waste) has become a growing health concern. The objective of this study was to measure the effect of exposure to e-waste on respiratory symptoms and on lung function parameters in workers involved in informal recycling activities in Cotonou city, Benin. Methods This was a cross-sectional study, in which exposed e-waste workers in Cotonou city were randomly selected. A matching nonexposed group based on age and sex was recruited from the general population. Respiratory symptoms were investigated using a questionnaire adapted from the British Medical Research Council's standardized respiratory questionnaire. Participants underwent lung function test using a portable spirometer (MIR SPIROBANK). Data were analyzed with STATA version 15 software. Results The overall prevalence of respiratory symptoms in e-waste workers was statistically higher in the exposed group (33.1% vs. 21.6%; p = 0.027). Chest tightness (11.8% vs. 2.1%; p = 0.003) and breathlessness (6.8% vs. 1.4%; p = 0.018) were the most reported symptoms by e-waste workers. Lung function testing showed a higher proportion of disorders among e-waste workers (25.0% vs. 14.9%, p = 0.029), with a higher proportion of probable restrictive (10.8% vs. 2.7, p = 0.005) and mixed (4.1% vs. 0%, p = 0.013) ventilatory disorders. Handling or working with e-waste was found associated with a significant reduction in forced expiratory volume in one second (FEV1) by 0.4 L (95% CI: 0.3-0.6) and forced vital capacity (FVC) by 0.75 L (95% CI: 0.6-0.9) after adjustment for age, BMI, smoking habits, asthma history, and daily income. Conclusion Work involving e-waste is associated with a higher prevalence of respiratory symptoms and with an increased risk of FEV1 and FVC decline, as well as of lung function impairment, particularly of restrictive disorders. Further studies to better clarify this association are needed. Awareness on this major public health threat should be raised in other sub-Saharan and Asian urban areas.","PeriodicalId":46434,"journal":{"name":"Pulmonary Medicine","volume":"58 1","pages":""},"PeriodicalIF":4.3,"publicationDate":"2022-02-24","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"83821337","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}

{"title":"Outcome of Newborns with Tracheoesophageal Fistula: An Experience from a Rapidly Developing Country: Room for Improvement.","authors":"Amal Al-Naimi,&nbsp;Sara G Hamad,&nbsp;Abdalla Zarroug","doi":"10.1155/2022/6558309","DOIUrl":"https://doi.org/10.1155/2022/6558309","url":null,"abstract":"<p><strong>Methods: </strong>This is a retrospective review of the medical electronic charts of patients with TEF that were followed at Sidra Medicine in the state of Qatar. The review included the patients who were operated upon in the period of 2011-2021 but continued to follow at our institution in the period of 2018-2021. Demographic data, associated anomalies, preoperative, operative, and postoperative courses, and growth parameters were collected.</p><p><strong>Results: </strong>A total of 35 patients with TEF (24 males and 11 females) were collected. 49% were full term. We identified seven patients (20%) with isolated TEF, TEF with VACTERL association in 29% of our patients, other chromosomal anomalies in 17%, or associated with other anomalies (not related to VACTERL) in 34% of the patients. The majority of the patients (94%) were of type C-TEF (TEF with esophageal atresia-EA/TEF). All patients were operated except for one patient who died at 2 days of life due to cardiac complications. Median age at which surgery was performed was 2 days (range 1-270 days). Median follow-up was 32 months (range 7-115 months). Immediate postoperative complications were encountered in eleven patients (33%) and included anastomosis leak in 12%, air leak in 6%, sepsis in 6%, chylothorax in 3%, vocal cord palsy and fistula recurrence (combined) in 3%, and failure of TEF closure in 3% of the patients. Long-term respiratory complications were encountered in 43% of our patients. Long-term gastrointestinal complications included gastroesophageal reflux (GERD) in 63%, dysphagia in 31%, and anastomotic stricture in 34% of the patients. Growth was affected in around a quarter of the patients at 6 months after surgery and 22% at 12-month assessment postoperatively. While only five patients died at our institution, only one was directly related to failure of TEF closure and postoperative complications.</p><p><strong>Conclusion: </strong>This descriptive study reports the clinical outcome of TEF from a rapidly developing country. The distribution of the patients' characteristics and postoperative complications was almost comparable to those from developed countries. This study would aid in addressing the prognostic factors and establishment of evidence-based management pathways of newborns with TEF to improve the clinical outcome in our center and other pediatric tertiary centers in developing countries.</p>","PeriodicalId":46434,"journal":{"name":"Pulmonary Medicine","volume":"2022 ","pages":"6558309"},"PeriodicalIF":4.3,"publicationDate":"2022-01-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9731754/pdf/","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"10330327","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}

{"title":"The Biology and Function of Tissue Inhibitor of Metalloproteinase 2 in the Lungs.","authors":"Louis Costanzo,&nbsp;Brian Soto,&nbsp;Richard Meier,&nbsp;Patrick Geraghty","doi":"10.1155/2022/3632764","DOIUrl":"https://doi.org/10.1155/2022/3632764","url":null,"abstract":"<p><p>Tissue inhibitors of matrix metalloproteinases (TIMP) are a family of four endogenous proteins that primarily function to inhibit the activities of proteases such as the matrix metalloproteinases (MMP). Altered MMP/TIMP ratios are frequently observed in several human diseases. During aging and disease progression, the extracellular matrix (ECM) undergoes structural changes in which elastin and collagens serve an essential role. MMPs and TIMPs significantly influence the ECM. Classically, elevated levels of TIMPs are suggested to result in ECM accumulation leading to fibrosis, whereas loss of TIMP responses leads to enhanced matrix proteolysis. Here, we outline the known roles of the most abundant TIMP, TIMP2, in pulmonary diseases but also discuss future perspectives in TIMP2 research that could impact the lungs. TIMP2 directly inhibits MMPs, in particular MMP2, but TIMP2 is also required for the activation of MMP2 through its interaction with MMP14. The protease and antiprotease imbalance of MMPs and TIMPs are extensively studied in diseases but recent discoveries suggest that TIMPs, specifically, TIMP2 could play other roles in aging and inflammation processes.</p>","PeriodicalId":46434,"journal":{"name":"Pulmonary Medicine","volume":"2022 ","pages":"3632764"},"PeriodicalIF":4.3,"publicationDate":"2022-01-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9825218/pdf/","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"10506229","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}

{"title":"Correlation between Reduced FEF25-75% and a Positive Methacholine Challenge Test in Adults with Nonobstructive Baseline Spirometry.","authors":"Irfan Shafiq,&nbsp;Mateen Haider Uzbeck,&nbsp;Zaid Zoumot,&nbsp;Mohamed Abuzakouk,&nbsp;Niyas Parappurath,&nbsp;Ali Saeed Wahla","doi":"10.1155/2021/6959322","DOIUrl":"https://doi.org/10.1155/2021/6959322","url":null,"abstract":"<p><strong>Objective: </strong>To clarify whether in adults with a nonobstructive spirometry a reduced FEF25-75% is associated with a positive methacholine challenge test (MCT).</p><p><strong>Methods: </strong>Data was collected for all the patients who had a MCT done between April 2014 and January 2020 but had nonobstructive baseline spirometry. Logistic regression was utilized to estimate the log odds of a positive methacholine test as a function of FEF25-75% and also for age, gender, BMI, FEV1, and FEV1/FVC.</p><p><strong>Results: </strong>Out of 496 patients, 187 (38%) had a positive MCT. Baseline characteristics in two groups were similar except that patients with positive MCT were younger (32 ± 11.57 vs. 38 ± 13.25 years, respectively, <i>p</i> < 0.001). Mean FEF25-75% was lower in MCT positive (3.12 ± 0.99 L/s) vs. MCT negative (3.39 ± 0.97 L/s) patients, <i>p</i> = 0.003. Logistic regression results suggest that MCT outcome is inversely related to FEF25-75%, age, and gender. Specifically, as FEF25-75% percentage of predicted value increases, the log odds of a positive MCT decrease (odds ratio (OR) = 0.90, 95% confidence intervals (CI) = 0.84-0.96, <i>p</i> = 0.002). Also, as age increases, the log odds of a positive MCT decrease (OR = 0.95, 95%CI = 0.94-0.97, <i>p</i> < 0.001).</p><p><strong>Conclusions: </strong>Reduced FEF25-75% in adults with nonobstructive spirometry can predict a positive response to MCT in younger patients. However, this relationship becomes weaker with increasing age.</p>","PeriodicalId":46434,"journal":{"name":"Pulmonary Medicine","volume":"2021 ","pages":"6959322"},"PeriodicalIF":4.3,"publicationDate":"2021-12-29","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8731260/pdf/","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"39800927","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}

{"title":"Warfarin Use Is Associated with Increased Mortality at One Year in Patients with Idiopathic Pulmonary Fibrosis.","authors":"Syeda Fatima Naqvi,&nbsp;Amir Humza Sohail,&nbsp;Dhairya A Lakhani,&nbsp;James Maurer,&nbsp;Sarah Sofka,&nbsp;Yousaf B Hadi","doi":"10.1155/2021/3432362","DOIUrl":"https://doi.org/10.1155/2021/3432362","url":null,"abstract":"<p><strong>Objectives: </strong>We studied the safety and efficacy of warfarin compared to direct acting oral anticoagulant use in patients with IPF.</p><p><strong>Methods: </strong>We conducted a retrospective cohort study of all patients with IPF who were prescribed warfarin or direct acting oral anticoagulants (DOACs) for cardiac or thromboembolic indications and followed at our institute for their care. Univariate tests and multivariable logistic regression analyses were used for assessing association of variables with outcomes.</p><p><strong>Results: </strong>A total of 73 patients were included in the study with 28 and 45 patients in the warfarin and DOAC groups, respectively. Univariable analysis revealed a significant difference in mortality in one year between warfarin and DOAC groups (7/28 vs. 3/45, <i>p</i> value 0.027). Significantly more patients in the warfarin group suffered an exacerbation that required hospitalization within one year (9/28 vs. 5/45, <i>p</i> value 0.026). Multivariate logistic regression analysis showed that anticoagulation with warfarin was independently associated with mortality at one-year follow-up (OR: 77.4, 95% CI: 5.94-409.3, <i>p</i> value: 0.007).</p><p><strong>Conclusion: </strong>In our study of patients with IPF requiring anticoagulants, we noted statistically significant higher mortality with warfarin anticoagulation when compared to DOAC use. Further larger prospective studies are needed to confirm these findings.</p>","PeriodicalId":46434,"journal":{"name":"Pulmonary Medicine","volume":"2021 ","pages":"3432362"},"PeriodicalIF":4.3,"publicationDate":"2021-11-25","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8639231/pdf/","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"39695822","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}